跳至主要内容
临床试验/EUCTR2011-001148-31-GB
EUCTR2011-001148-31-GB进行中(未招募)1 期

A pilot clinical trial with the iron chelator Deferiprone in Parkinson's disease - Pilot clinical trial iron chelator Deferiprone in Parkinson's Vs1

Imperial College London0 个研究点目标入组 48 人开始时间: 2011年8月17日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • All patients will have a diagnosis of clinical idiopathic Parkinson’s disease (UK PDS Brain Bank diagnostic criteria) disease duration < 5 yrs with a stable response to standard antiparkinson's drug e.g. L-DOPA or dopamine agonist. Aged 50-75 years.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 24
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 24

排除标准

  • Patients with other neurological conditions, psychiatric disorders and history of depression will be excluded as will patients with a history of diabetes, renal or liver disease, blood disorders, immune compromised, history of agranulocytosis, or condition contraindicatory for MRI examination e.g pacemaker. Outside age bracket

研究者

相似试验